No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CDXC ChromaDex
- 5.490
- +0.080+1.48%
Close Dec 20 16:00 ET
- 5.490
- -0.001-0.01%
Post 20:01 ET
419.34MMarket Cap274.50P/E (TTM)
5.550High5.250Low1.20MVolume5.310Open5.410Pre Close6.56MTurnover2.45%Turnover RatioLossP/E (Static)76.38MShares7.97452wk High12.20P/B270.12MFloat Cap1.36052wk Low--Dividend TTM49.20MShs Float23.660Historical High--Div YieldTTM5.55%Amplitude0.052Historical Low5.447Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
ChromaDex Corporation's (NASDAQ:CDXC) 28% Cheaper Price Remains In Tune With Revenues
Even Though ChromaDex (NASDAQ:CDXC) Has Lost US$73m Market Cap in Last 7 Days, Shareholders Are Still up 389% Over 1 Year
Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)
Ladenburg Thalmann Maintains ChromaDex(CDXC.US) With Buy Rating, Raises Target Price to $6.8
Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Maintains Target Price $8
An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 21% Undervalued
Heat List
US
Overall
Symbol
Price
% Chg
No Data